About this trial
Smoking is a significant risk factor for heart, lung, and respiratory system diseases, and is particularly prevalent among young people and university students. In Turkey, tobacco use is high in the 15-24 age group, and smoking rates among university students are reported to be between 20% and 43%. Besides causing COPD and other respiratory diseases, smoking negatively impacts performance by increasing fatigue, dyspnea, and pain during exercise. It impairs lung function, reducing respiratory volumes such as FVC and FEV1. PNF and chest mobility exercises targeting the chest area can improve respiratory parameters by increasing respiratory muscle function and thoracic mobility. Recent studies show that chest PNF techniques have positive effects on lung function, chest expansion, and some physiological parameters, especially in smokers.
Eligibility criteria
Qualifiers
Age of 18-24 years
Fagerström Nicotine Dependence Questionnaire score ≥4
Smoking for at least 2 years
Daily smoking ≥5 cigarettes and at least 90 pack-years. Stable condition (no acute respiratory infection in the last 4 weeks).
Disqualifiers
Cardiac event or lung surgery in the last 6 months
Respiratory problems such as COPD, asthma
Orthopedic and neurological problems
Termination of volunteering
Trial design
Treatments tested in this trial
- Chest PNF Techniques Group
- Chest Mobility Exercises Group